Livzon Pharmaceutical Group Inc (000513) — Financial Flexibility Index
Livzon Pharmaceutical Group Inc (000513) has a Financial Flexibility Index of 0.09x as of December 2025. Free cash flow of CN¥704.42 Million (operating CF CN¥625.70 Million minus capex CN¥78.72 Million) represents 0% of total liabilities (CN¥8.20 Billion). Check Livzon Pharmaceutical Group Inc cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Livzon Pharmaceutical Group Inc Financial Flexibility Index (1998–2025)
Historical Financial Flexibility Index trend for Livzon Pharmaceutical Group Inc across 28 annual periods. For the full cash flow conversion analysis, see 000513 operating cash flow.
Annual Financial Flexibility Index for Livzon Pharmaceutical Group Inc (1998–2025)
Year-by-year free cash flow to debt coverage for Livzon Pharmaceutical Group Inc. Explore 000513 operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.46x | CN¥3.75 Billion | CN¥3.18 Billion | CN¥8.20 Billion | ▲ +23.2% |
| 2024 | 0.37x | CN¥3.55 Billion | CN¥2.98 Billion | CN¥9.55 Billion | ▼ -6.1% |
| 2023 | 0.40x | CN¥4.07 Billion | CN¥3.25 Billion | CN¥10.28 Billion | ▲ +5.9% |
| 2022 | 0.37x | CN¥3.71 Billion | CN¥2.77 Billion | CN¥9.93 Billion | ▼ -6.2% |
| 2021 | 0.40x | CN¥3.21 Billion | CN¥1.90 Billion | CN¥8.06 Billion | ▼ -1.4% |
| 2020 | 0.40x | CN¥2.81 Billion | CN¥2.16 Billion | CN¥6.95 Billion | ▲ +6.4% |
| 2019 | 0.38x | CN¥2.17 Billion | CN¥1.77 Billion | CN¥5.70 Billion | ▲ +24.0% |
| 2018 | 0.31x | CN¥1.74 Billion | CN¥1.27 Billion | CN¥5.69 Billion | ▼ -11.3% |
| 2017 | 0.35x | CN¥1.61 Billion | CN¥1.32 Billion | CN¥4.66 Billion | ▼ -28.3% |
| 2016 | 0.48x | CN¥1.65 Billion | CN¥1.28 Billion | CN¥3.42 Billion | ▲ +11.9% |
| 2015 | 0.43x | CN¥1.40 Billion | CN¥927.79 Million | CN¥3.27 Billion | ▲ +0.1% |
| 2014 | 0.43x | CN¥1.38 Billion | CN¥717.39 Million | CN¥3.22 Billion | ▼ -6.5% |
| 2013 | 0.46x | CN¥1.36 Billion | CN¥439.99 Million | CN¥2.96 Billion | ▼ -16.9% |
| 2012 | 0.55x | CN¥1.36 Billion | CN¥593.96 Million | CN¥2.45 Billion | ▼ -16.8% |
| 2011 | 0.66x | CN¥1.06 Billion | CN¥708.20 Million | CN¥1.59 Billion | ▼ -30.0% |
| 2010 | 0.95x | CN¥970.25 Million | CN¥633.30 Million | CN¥1.02 Billion | ▲ +36.2% |
| 2009 | 0.70x | CN¥626.29 Million | CN¥494.88 Million | CN¥898.92 Million | ▲ +80.4% |
| 2008 | 0.39x | CN¥420.70 Million | CN¥345.18 Million | CN¥1.09 Billion | ▲ +8.5% |
| 2007 | 0.36x | CN¥339.83 Million | CN¥248.55 Million | CN¥954.80 Million | ▼ -5.8% |
| 2006 | 0.38x | CN¥406.91 Million | CN¥226.46 Million | CN¥1.08 Billion | ▼ -16.3% |
| 2005 | 0.45x | CN¥417.79 Million | CN¥161.07 Million | CN¥925.20 Million | ▲ +41.8% |
| 2004 | 0.32x | CN¥327.94 Million | CN¥181.46 Million | CN¥1.03 Billion | ▼ -24.7% |
| 2003 | 0.42x | CN¥403.57 Million | CN¥300.01 Million | CN¥954.70 Million | ▼ -3.1% |
| 2002 | 0.44x | CN¥317.27 Million | CN¥213.65 Million | CN¥727.05 Million | ▲ +17.9% |
| 2001 | 0.37x | CN¥236.63 Million | CN¥155.15 Million | CN¥639.37 Million | ▲ +115.1% |
| 2000 | 0.17x | CN¥100.01 Million | CN¥38.52 Million | CN¥581.24 Million | ▼ -68.6% |
| 1999 | 0.55x | CN¥319.67 Million | CN¥246.23 Million | CN¥583.95 Million | ▲ +1792.1% |
| 1998 | 0.03x | CN¥13.53 Million | CN¥-18.21 Million | CN¥467.61 Million | — |